Fig. 7

GSH rescues ADSCs from ferroptosis by activating the SLC7A11/GPX4 axis. a Cell viability in the OGD model at different concentrations of GSH (n = 3). b Attenuation of decreased cell viability in the OGD- and erastin-treated groups by GSH (n = 3). c Intracellular reactive oxygen species (ROS) levels determined by flow cytometry (n = 3). d BODIPY staining for lipid peroxidation in ADSCs (n = 3). e, f Intracellular MDA and SOD levels in each treatment group (n = 3). g, h Protein expression and quantification of GPX4, SLC7A11 by western blotting (n = 3). Full-length blots are presented in Additional file 4. Data are presented as the mean ± SD. *p < 0.05, **p < 0.01